Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer - Subset analysis of the ESPAC-1 data

International Journal of Cancer

Volumn 124, Issue 12, 2009, Pages 2960-2965

  Carter, Ross ^a   Stocken, Deborah D ^b   Ghaneh, Payla ^c   Bramhall, Simon R ^b   Olah, Attila ^d   Kelemen, Deszo ^e   Bassi, Claudio ^f   Friess, Helmut ^g   Dervenis, Christo ^h   Spry, Nigel ⁱ   Büchler, Markus W ^j   Neoptolemos, John P ^c,k  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d Petz Aladar Teaching Hospital   (Hungary)

^e UNIVERSITY OF PÉCS   (Hungary)

^f UNIVERSITY OF VERONA   (Italy)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^h AGIA OLGA HOSPITAL   (Greece)

ⁱ SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^j UNIVERSITY OF HEIDELBERG   (Germany)

^k Liverpool CR UK Centre   (United Kingdom)

more..

Author keywords

Chemoradiation; Chemotherapy; Pancreatic cancer; Quality of life

Indexed keywords

FLUOROURACIL; FOLINIC ACID; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PANCREAS CARCINOMA; PANCREAS TUMOR; PROGNOSIS; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, PANCREATIC DUCTAL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LEUCOVORIN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 65649151336     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24270     Document Type: Article

References (17)

1. Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H, Bassi C, Falconi M, Pederzoli P, Dervenis C, Fernandez-Cruz L, Lacaine L, et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 2001;358:1576-1585 (Pubitemid 33101907)
2. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, Falconi M, Pederzoli P, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200-1210 (Pubitemid 38339364)
3. Stocken DD, Büchler MW, Dervenis C, Bassi C, Jeekel H, Klinkenbijl JHG, Bakkevold KE, Takada T, Amano A, Neoptolemos JP. Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer 2005;92:1372-1381 (Pubitemid 40705002)
4. American Society of Clinical Oncology. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 1996;14:671-679
5. Barr H, Krasner N. Prospective quality-of-life analysis after palliative photoablation for the treatment of malignant dysphagia. Cancer 1991;68:1660-1664
6. Blazeby JM, Nicklin J, Brookes ST, Winstone K, Alderson D. Feasibility of quality of life assessment in patients with upper gastrointestinal tract cancer. Br J Cancer 2003;89:497-501. (Pubitemid 37026432)
7. Velikova G, Brown JM, Smith AB, Selby PJ. Computer-based quality of life questionnaires may contribute to doctor-patient interactions in oncology. Br J Cancer 2002;86:51-59 (Pubitemid 34146340)
8. Billingham LJ, Abrams KR. Simultaneous analysis of quality of life and survival data. Stat Methods Med Res 2002;11:25-48. (Pubitemid 34201830)
9. Cancer Therapy Evaluation Program. Common toxicity criteria. Division of Cancer Treatment & Diagnosis. Natl Inst Health 1998;version 2.0.
10. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JCJM, Kaasa S, Klee M, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376 (Pubitemid 23073154)
11. Fayers P, Machin D. Quality of life: assessment, analysis and interpretation. Chichester: J Wiley & Sons, 2000.
12. Qain W, Parmer MKB, Sambrook RJ, Fayers PM, Girling DJ, Stephens RJ. Analysis of messy longitudinal data from a randimised clinical trial. Stat Med 2000;19:2657-2674 (Pubitemid 30727397)
13. Efron B, Tibshirani RJ. An introduction to the bootstrap. Monographs on statistics and applied probability 57. New York: Chapman & Hall, 1993.
14. Nieveen van Dijkum EJ, Kuhlmann KFD, Terwee CB, Obertop H, de Haes JCJM, Gouma DJ. Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma. Br J Surg 2005;92:471-477 (Pubitemid 40523912)
15. Blazeby JM, Farndon JR, Donovan J, Alderson D. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 2000;88:1781-1787 (Pubitemid 30212985)
16. Zieren HU, Zippel K, Zieren J, Muller JM. Quality of life after surgical treatment of gastric carcinoma. Eur J Surg 1998;164:119-125 (Pubitemid 28092786)
17. Goodwin PJ, Black JT, Bordeleau LJ, Ganz PA. Health-related quality-of-life measurement in randomized clinical trials in breast cancer-taking stock. J Natl Cancer Inst 2003;95:263-281 (Pubitemid 36336477)